Ruvi AI’s (RUVI) Presale Rockets to 70% as Institutions Favor It Over Cardano (ADA), Fueled by CoinMarketCap Listing and Early Bonuses

Analytics Insight
Jul 29, 2025 18:00
Market Trends
1 views
aianalyticsbig-databusiness

Summary

Ruvi AI’s (RUVI) presale has surged to 70% completion, attracting significant institutional interest and outpacing Cardano (ADA) due to its recent CoinMarketCap listing and early investor bonuses. This momentum highlights growing institutional confidence in AI-driven blockchain projects, signaling increased integration of AI technologies within the crypto sector.

Related Articles

How to Rank on ChatGPT: Practical Tips to Improve Discoverability

Analytics InsightJul 30

The article offers practical strategies for improving visibility in ChatGPT’s responses, such as optimizing content with clear, authoritative information and using relevant keywords. It highlights the growing importance of AI-driven search and discoverability, suggesting that content creators must adapt their approaches to remain prominent in conversational AI platforms. This shift underscores how AI is reshaping digital content strategies and search optimization.

Show HN: I made a Word Search game with the help of an AI assistant

Hacker News - AIJul 30

A non-developer created a word search game in a weekend using ChatGPT for guidance on technical aspects like grid generation and mobile optimization. This showcases how AI assistants can empower individuals without specialized backgrounds to quickly build functional, user-friendly applications. The project highlights AI’s potential to lower barriers to entry in software development.

Efficient algorithm by MIT solves AI symmetry problem impacting drug discovery

Hacker News - AIJul 30

MIT researchers have developed a new algorithm that efficiently handles symmetric data in machine learning, addressing a key challenge in AI models used for drug discovery. This advancement enables faster and more accurate analysis of molecular structures, potentially accelerating the development of new medicines and improving AI performance in scientific research.